Activ Surgical Granted Third U.S. Patent for ActivSight™ Imaging Module - Activ Surgical

Author: Tom Calef, CTO, Activ Surgical

Today marks yet another milestone in Activ Surgical’s history as we announce that the company was issued its third patent from the United States Patent and Trademark Office (USPTO) for our ActivSightTM interoperable imaging module. The ActivSight module is designed to interface with existing vision systems to enable surgeons to view in real-time critical physiological structures and functions, like blood flow, that cannot be seen with the naked eye while in the operating room.

Our first U.S. patent for the ActivSight imaging module was issued in March of 2021, with a second patent granted in November 2021. This third patent – U.S. Patent No. 11,206,991 – was issued in December 2021 and protects our proprietary system and methods for processing laser speckle signals, which are currently delivered via the ActivSight module. This patent protects our intellectual property that provides intraoperative visual data and images on blood flow and perfusion not currently available to surgeons through existing technologies. The three patents are mission-critical for Activ Surgical and bring us one step closer to our goal of enhancing patient outcomes and democratizing surgical care around the world. I am incredibly proud of our staff, particularly the inventors of this technology, John Oberlin and Manny DeMaio. As a company, we have many patents pending for our inventions worldwide, which cements our position as a disruptor in the digital surgery space. Stay tuned for more news from Activ Surgical as we march towards commercial availability of the ActivSight module later this year.

New Partner Joins Fusion Marketplace, Bringing Additional Support for Travel Healthcare Professionals

Press Release - Jul 1, 2022 09:00 EDT 

OMAHA, Neb., July 1, 2022 (Newswire.com) - The team at Fusion Marketplace has welcomed a new partner onto the traveler-first driven job platform. This adds more healthcare jobs to the platform, giving more control to healthcare travelers as they navigate their careers.

"The whole team at Fusion Marketplace is enthusiastic about the new partnership with MedUS Healthcare," said Dan Scardina, Fusion Marketplace President. "MedUS shows so much passion for their healthcare professionals, and we are all excited to see even more of that added to Fusion Marketplace." 

Healthcare professionals have gained a significant amount of control over their careers through Fusion Marketplace. New features and the addition of several new agencies have created more options for travelers ready to get in the driver's seat when it comes to their future in the healthcare industry. Now they can be picky about where they go, what agency they work with, what their shift looks like, and other deciding factors when choosing an assignment. 

This platform gives healthcare travelers the ability to compare pay between jobs, rate and review their recruiters, and choose housing options among other features, all while they're able to choose where they want to make their next mark.

To learn more about Fusion Marketplace and to create your traveler profile, go to fusionmarketplace.com. 

About MedUS Healthcare:

MedUS Healthcare, formerly Axis Providers, is a Joint Commission-certified staffing company that specializes in the recruitment, placement, and partnership of travel nurses and other healthcare professionals nationwide. We pride ourselves on tailoring our high-paying travel assignments to the skillset of our caregivers. We are affiliated with the best facilities across the U.S., managed and operated by industry-rich professionals, and driven to deliver the BEST travel experience to the BEST healthcare professionals in the industry.

About Fusion Marketplace:

Fusion Marketplace is a staffing recruitment platform where healthcare travelers are in control. Healthcare travelers now have more career, agency, recruiter, and lifestyle choices in one convenient location. Unknowns known. Learn more at fusionmarketplace.com.

Source: Fusion Marketplace

HHS Says to Strengthen Cyber Posture at Healthcare Organizations

VirtualHealth & WebMD Team Up to Deliver Krames Health Education

VirtualHealth, the industry-leading SaaS solution for comprehensive medical management, today announced a partnership with WebMD Provider Services, which helps health systems and plans build enduring relationships and educate individuals at every stage in their health care journey, from discovery to recovery. Together, VirtualHealth and WebMD Provider Services will enable health plans to coach their high- and rising-risk members in care management with direct access to Krames’ trusted, industry-leading multimedia health information through VirtualHealth’s HELIOS® platform.

Through VirtualHealth’s partnership with WebMD Provider Services, care managers will be able to provide health plan members with Krames evidence-based, medically reviewed, and motivating health education materials from within VirtualHealth’s leading care management system, HELIOS®.

“Delivering personalized healthcare at scale is the future and we’re committed to making it a reality by reaching consumers at every point of their care journey with content contextualized for that moment,” said Ann Bilyew, Senior Vice President Health and Group General Manager, WebMD Provider Services. “By partnering with VirtualHealth, WebMD Provider Services advances health plans’ goals of member-centered health care, improving the member experience, empowering better population outcomes, and assisting in lowering the total cost of care.”

WebMD Provider Services activates the member health journey through Krames print, digital, and video content integrated into care management workflows. Krames’ evidence-based, clinically reviewed, culturally appropriate, and personalized health education builds deeper, enduring relationships that retain and attract members, supporting improved quality measures, member satisfaction scores, plan accreditation, and higher ratings.

Read the release in its entirety here.

About VirtualHealth 
HELIOS® by VirtualHealth is the first comprehensive care management platform purpose-built to power the entire ecosystem of value-based care. Utilized by some of the most innovative health plans in the country to manage millions of members, HELIOS streamlines person-centered care with intelligent case, disease, and utilization management workflows, unmatched data integration, broad-spectrum collaboration, patient engagement, and configurable analytics and reporting. Named one of the fastest-growing companies in North America by Deloitte in 2018 and 2019 and a top-rated solution by KLAS Research, VirtualHealth empowers healthcare organizations to achieve enhanced outcomes while maximizing efficiency, improving transparency, and lowering costs. For more information, visit www.virtualhealth.com.

About WebMD Provider Services

WebMD Provider Services, a division of WebMD Health Corp., is a strategic partner to health systems and payers, offering a unified engagement experience for patients across their entire health journey from discovery to recovery. Through extensive health information audience reach, health care provider networks, medically-reviewed patient education content and deep integration into patient touchpoints, WebMD Provider Services supports health systems and payers in building deeper, enduring relationships with patients. The results are streamlined clinical and care management processes that enable better member and patient outcomes.

About WebMD Health Corp.

WebMD, an Internet Brands company, is at the heart of the digital health revolution that is transforming the healthcare experience for consumers, patients, healthcare professionals, employers, health plans and health systems. Through public and private online portals, mobile platforms, and health-focused publications, WebMD delivers leading-edge content and digital services that enable and improve decision-making, support and motivate health actions, streamline and simplify the healthcare journey, and improve patient care.

The WebMD Health Network includes WebMD Health, Medscape, Jobson Healthcare Information, MediQuality, Frontline, Vitals Consumer Services, Aptus Health, Krames, PulsePoint, The Wellness Network, SanovaWorks, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org® and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.

 

VillageMD Welcomes Velda Rose Medical Center and Expands its Footprint in the Phoenix Area

CHICAGO and MESA, Az. – June 14, 2022 – VillageMD announced today it acquired Velda Rose Medical Center, a primary care practice founded by Mark Goldberg, M.D. Patients in the Mesa and Phoenix area can visit Dr. Goldberg and his care team, including Michael Demko, DO, David Izenberg, DO, Uma Gopakumar, DNP, Leslie Stumpff, LMSW, and Kyle Hunsaker, PA, at Village Medical later this summer.

“At VillageMD, we’re continuing to grow in our communities with trusted physicians along with their experienced care teams to offer increased access to high-quality primary care,” said Paul Martino, co-founder and chief growth officer of VillageMD. “We’re thrilled to welcome Dr. Goldberg and his team to Village Medical.”

Village Medical offers a comprehensive suite of primary care services including preventative care, treatment for illness and injury, and management of chronic conditions such as diabetes, congestive heart failure, chronic obstructive pulmonary disease (COPD) and kidney disease. Phoenix and Mesa patients can learn more about the services here.

“I’m excited to join Village Medical and continue the comprehensive, compassionate care for our patients. I also look forward to welcoming new patients who are looking for comprehensive primary care right in their community,” said Dr. Goldberg, who has more than 30 years of experience as a practicing physician in the East Valley community. “I believe your healthcare experience should be accessible and personal and that’s exactly what Village Medical offers their patients.”

The well-established primary care practice will continue to offer comprehensive primary care services in Mesa while also offering enhanced technology and support for their clinicians.  

Village Medical patients have access to same-day appointments and virtual health visits with a Village Medical provider. Additionally, Village Medical patients will be able to take advantage of Village Medical at Home, which provides in-home primary care visits with experienced primary care providers. Village Medical patients also benefit from VillageMD’s patent-pending docOS® operating platform, which helps care teams identify and close gaps in care and helps patients be better informed about their health and care.

To learn more, make an appointment or view all Village Medical locations, please visit www.villagemedical.com.  

About VillageMD

VillageMD, through its subsidiary Village Medical, is a leading, national provider of value-based primary care services. VillageMD partners with physicians to provide the tools, technology, operations, staffing support and industry relationships to deliver high-quality clinical care and better patient outcomes, while reducing the total cost of care. The Village Medical brand provides primary care for patients at traditional free-standing practices, Village Medical at Walgreens practices, at home and via virtual visits. VillageMD and Village Medical have grown to 22 markets and are responsible for more than 1.6 million patients. VillageMD is a leading participant in CMS innovation programs and will apply to participate in the upcoming ACO REACH model, which helps providers deliver better outcomes for patients and create healthier communities through value-based care. To learn more, please visit www.villageMD.com.

 

Bridge Patient Portal Launches its Next-Generation Telehealth Solution

    DALLAS, TX, January 07, 2021 /24-7PressRelease/ -- Bridge Patient Portal today announced the launch of its new telehealth solution that leverages Zoom for Healthcare. The addition of telehealth functionality further expands the company's suite of patient engagement features and was developed to meet the increasingly complex needs of patients and health systems for interconnected virtual care during and after the pandemic.

The healthcare industry has witnessed a surge in the acquisition of telehealth tools in an effort to quickly react to urgent and unexpected demand in 2020. However, current platforms don't connect different touch points along the patient journey or offer long-term solutions that integrate with companies' existing digital tools. Bridge was approached by its clients to develop a HIPAA-compliant telehealth solution with high-quality video as part of the larger patient engagement ecosystem, whereby a patient can book a video visit which integrates with other features such as appointment scheduling, intake, bill pay, and secure messaging, all through the same platform.

How It Works
Bridge connects with a provider's electronic health record (EHR) and revenue cycle management (RCM) system(s) to allow patients to request a telehealth encounter by selecting the provider, date, and type of appointment. Once confirmed, Zoom creates a unique video visit room code for that appointment, and an email confirmation plus notification reminders are triggered at preset intervals before the appointment.

Before the appointment begins, the patient will receive a secure notification with a link to the portal that allows them to securely join the Zoom meeting, with all of Zoom's same familiar functionality. This Zoom link can also be integrated into Bridge's intake module, providing patients with a seamless virtual visit experience.

The platform's newest feature can be purchased as an add-on module to Bridge's base Patient Portal product.

"We're excited to launch a fully automated telehealth solution different from anything else on the market. What makes Bridge unique is that our telehealth module is part of a comprehensive patient engagement platform with an interconnected suite of features such as self-scheduling, appointment reminders, bill pay, secure messaging and intake. This allows providers to take a holistic approach to telehealth and develop automated, custom workflows for greater efficiency, and provide patients with a single point of access from start-to-finish for everything from booking an appointment to messaging with their provider after a visit," said John Deutsch, CEO of Bridge Patient Portal.

As telehealth becomes even more mainstream, Bridge is committed to further developing its solution to address the healthcare industry's needs for improved health and economic outcomes. This latest feature advances Bridge's position as an all-in-one patient engagement platform that provides in-demand and easy-to-use solutions across the entire patient journey--from pre-visit appointment scheduling and intake to post-encounter bill pay and prescription refills.

About Bridge Patient Portal
Bridge Patient Portal is an enterprise patient portal and engagement solution that empowers patients with self-service tools to better manage their care. The platform is client-branded and ideal for health organizations seeking to replace their existing online portals or connect to disparate EHR environments with a single, EHR-neutral patient portal platform, available on desktop, iOS, and Android. Founded in 2012 and headquartered in Dallas, Texas, Bridge Patient Portal has installations in many of healthcare's leading practices, hospitals, and health systems nationwide. For more information, visit
https://www.bridgepatientportal.com/ or call 800-467-2321.

# # #

HBCUs, Industry Partners Launch Initiative to Diversify and Strengthen Cybersecurity Workforce

HBCUs, Industry Partners Launch Initiative to Diversify and Strengthen Cybersecurity Workforce

  • Advancing Minorities' Interest in Engineering's HBCU Cybersecurity Industry Collaboration Initiative Pilot launches this year, bringing together four schools and three Fortune 100 corporate partners
  • Initiative aims to strengthen HBCU cybersecurity programming while developing diverse pipeline of cybersecurity career-ready students
  • Effort begins with nearly 600,000 open cybersecurity positions in the U.S. job market

, /PRNewswire/ -- To address the urgent cybersecurity talent needs in the U.S., Advancing Minorities' Interest in Engineering (AMIE) announced a new collaboration to support cybersecurity education at Historically Black Colleges and Universities (HBCUs).

Together with industry partners Abbott, Microsoft and Raytheon Technologies, the HBCU Cybersecurity Industry Collaboration Initiative Pilot aims to build curriculum capacity within HBCU engineering schools, positioning them as premier national academic institutions for cybersecurity, while creating a strong workforce of students well-prepared for the world's essential cybersecurity careers. The initiative expects to support HBCUs through curriculum development, research collaboration, faculty support and other resources. 

Right now, there are nearly 600,000 open cybersecurity jobs in the U.S. and experts anticipate there will be 3.5 million cybersecurity jobs open globally by 2025. 

"Our hope is that the initiative will enhance cybersecurity programming at HBCUs, helping connect students, especially African-American students, with opportunities to pursue cybersecurity certifications and degrees," said Veronica L. Nelson, AMIE's executive director. "This effort couldn't come at a more critical time. The U.S. greatly needs skilled cybersecurity workers. HBCU Engineering Schools represent a rich pipeline of untapped, diverse talent."

The 15 Accreditation Board for Engineering and Technology (ABET)-accredited HBCU Schools of Engineering produce more than 30% of the African-American engineers in the U.S. while representing less than 3% of the engineering universities in the U.S. Data from the U.S.

Department of Labor show Blacks and African-Americans make up only 11.8% of information security analysts in the U.S.

The initiative's pilot incorporates expertise and support from Abbott, Microsoft and Raytheon Technologies with the goal of aligning business needs to the pilot schools' cybersecurity curricula and research capabilities. The four HBCU pilot engineering schools of the 15 member schools of the Council of HBCU Engineering Deans are Hampton University, North Carolina A&T State University, Prairie View A&M University, and Virginia State University.

  • Professionals from Abbott, Microsoft and Raytheon Technologies will be guest lecturers, participate in mentoring programs and meet with faculty to better understand existing strengths and collaborate toward educating more cybersecurity professionals to help address the nation's talent gap.
  • Microsoft is providing funding and support as part of its Cybersecurity Skills Initiative.
  • Abbott is providing funding and hosting two Prairieview A&M University cybersecurity students for customized intern experiences during summer 2022.
  • Raytheon Technologies is providing funding and works with local students to showcase their cyber capabilities and provide opportunities for students to explore cyber careers.

"With the complete integration of Industry 4.0 or 'smart' technologies into so many aspects of our lives, VSU now sees almost every company we work with needing cybersecurity-trained professionals to secure their products, services, and their business operations," said Dr. Dawit Haile, Dean of the College of Engineering and Technology at Virginia State University. "This includes industries that we never would have previously considered in this context, like manufacturing, construction, and energy. VSU understands that cybersecurity skills are now part of a critical core knowledge base and we are committed to deliver a strong pipeline of students who are well-prepared in this area." 

The pilot will run through the end of 2022 with the goal of extending the initiative to the remaining 11 ABET-accredited HBCU Schools of Engineering in the future: Alabama A&M University, Florida A&M University, Howard University, Jackson State University, Morgan State University, Norfolk State University, Southern University, Tennessee State University, Tuskegee University, University of Maryland Eastern Shore and the University of the District of Columbia.

"In today's digital-first world, skilled cybersecurity workers are critical to ensuring the safety of our enterprise as well as the products and technologies we provide people to live better, healthier lives," said Sabina Ewing, Chief Information Officer, Abbott. "That's why, as a founding member of Advancing Minorities' Interest in Engineering, Abbott supports efforts like the HBCU Cybersecurity Industry Collaboration Initiative Pilot, which develops HBCU talent to build a diverse, innovative workforce that will meet the demands of today and tomorrow."

"We are excited to embark on this collaboration with AMIE to broaden education in cybersecurity at HBCUs," said Valecia Maclin, Microsoft Partner, Strategic Cloud Solutions, and AMIE board member. "The pre-eminent role that HBCUs play in graduating the best and brightest engineering talent in the U.S. coupled with our passion to extend global cybersecurity skilling is a unique collaboration and critical for the time that we are in. As part of our commitment to address America's cybersecurity workforce shortage, we look forward to working together to create a workforce that represents the diversity of our society."

"Closing the enormous cybersecurity skills gap and driving diversity in our talent pipeline are critical business imperatives for our company and industry," said Shanda Hinton, Chief Diversity Officer, Raytheon Technologies. "This alliance offers real world education, experience and mentorship opportunities to HBCU engineering students to help cultivate the next generation of cyber defenders."

About Advancing Minorities' Interest in Engineering:

Advancing Minorities' Interest in Engineering (AMIE) is a nonprofit coalition of corporations, government agencies and the 15 ABET-accredited Historically Black Colleges and Universities (HBCUs) Schools of Engineering. AMIE's purpose is to expand corporate and government alliances with the HBCU engineering programs to increase diversity in the engineering workforce. AMIE's commitment to fostering partnerships that attract, develop, recruit and graduate minorities in engineering has been its ongoing focus since its founding in 1992. Find out more about our efforts at www.amiepartnerships.org.

About Abbott:

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries. Connect at www.abbott.com.

About Microsoft:

Microsoft (Nasdaq "MSFT" @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

About Raytheon Technologies:

Raytheon Technologies Corporation is an aerospace and defense company that provides advanced systems and services for commercial, military and government customers worldwide. With four industry-leading businesses ― Collins Aerospace Systems, Pratt & Whitney, Raytheon Intelligence & Space and Raytheon Missiles & Defense ― the company delivers solutions that push the boundaries in avionics, cybersecurity, directed energy, electric propulsion, hypersonics and quantum physics. The company, formed in 2020 through the combination of Raytheon Company and the United Technologies Corporation aerospace businesses, is headquartered in Waltham, Massachusetts.

SOURCE Advancing Minorities' Interest in Engineering

For further information: Media: Michelle Horn, Microsoft, 917-363-1742, michellehorn@microsoft.com; Microsoft Media Relations, WE Communications, 425-638-7777, rapidresponse@we-worldwide.com

Q&A: Why Leading with Evidence is Necessary for Digital Therapeutics

Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream. The startup's CEO, Mike Rosenbluth, sat down with MobiHealthNews to discuss why Swing's first product is focused on fibromyalgia and what's necessary to encourage provider uptake of digital therapeutics. People with fibromyalgia and other chronic pain diseases may try to naturally figure out how to minimize symptoms in their lives, and how to change their lives to make their symptoms more manageable. And so, what ACT tries to do is to help people accept, which isn't so much to say that you're resigned to the disease, but to say that it's there, and you can live your best life alongside the symptoms and alongside the pain. So, it's really trying to think about how you can change your relationship with pain – which is a lot easier said than done - but trying to get to a point where you're living a fulfilling life where the symptoms of the disease are more an annoyance, rather than a central part of your life. We ended up speaking with a lot of physicians and a lot of patients, and really got pointed to fibromyalgia as a place to start. So, if you're a primary care physician or you're a rheumatologist, you don't have a pain psychologist in your Rolodex that you'll typically refer to unless you're in some specialty clinic or the Mayo Clinic or some chronic pain center, which most people don't have access to. But the general idea is, as we've been really understanding more and more about this patient population, realizing that a digital therapeutic can be really powerful, and additionally powerful would be to provide these patients with a care specialist that truly understands their disease.

Apixio’s New Apicare AuthAdvisor Leverages Machine Learning, Predictive Decision-Making to Automate Approvals & Reduce Manual Workload by more than 50%

AI-Driven Solution Uses Historical Decision Data to Build Custom Data Model & Automate Approvals

SAN MATEO, Calif., March 1, 2022 – Apixio, Inc., the healthcare analytics company, today announced the launch of its new Apicare AuthAdvisor, which uses machine learning and predictive analytics to automate prior authorization decisions for payers. By leveraging historical decision data, AuthAdvisor automates approval for payers, medical benefit managers, and other vendors to deliver decisions within seconds rather than days, and reduces manual reviews by over 50%.

According to the Council for Affordable Quality Healthcare (CAQH),” the cost to complete a prior authorization remains the single highest cost for the healthcare industry at $13.40 per manual transaction and $7.19 per partially electronic web portal transaction”. Not only is it costly, but it is also an administrative burden with manual reviews sometimes taking days or weeks, which delays patient treatments, creates obstacles to care, and potentially negatively impacts clinical outcomes.

Apixio’s AuthAdvisor solves these problems by automatically approving diagnostics and procedures based on historical data and decisions made by the provider and payer.

“This is a new way to use data science to accelerate one of the most burdensome aspects of healthcare delivery,” said Apixio CEO Sachin Patel. “AuthAdvisor relies on the accuracy of an organization’s past decisions to process approvals, rather than relying on rules-based approaches that are tedious to maintain and often result in a high number of manual reviews. With AuthAdvisor, approvals are delivered at the speed and scale that today’s high-performance healthcare environments demand.”

With Apixio’s Apicare AuthAdvisor solution, organizations can:

  • Drive cost savings by reducing the volume of unnecessary reviews with automated decisions driven by our AI models
  • Fine-tune thresholds with user-enabled controls on a procedure-by-procedure basis
  • Deliver immediate results by deploying into existing workflows through APIs
  • Enhance provider and member satisfaction with timely feedback on requests

“The AuthAdvisor system is transparent and customizable, giving payers and benefits managers the visibility and flexibility they need to feel confident in the decisions being made,” Patel said. “The latest addition to our AI platform, this technology has the potential to not only save tremendous time and money but also greatly improve care delivery and member satisfaction for millions of Americans.”

AuthAdvisor is already active in 16 states, automating authorization requests for over 4,000 different procedures. Apixio will be showcasing its value-based care platform, including Apicare AuthAdvisor, at both RISE National on March 7-9 in Nashville and  HIMSS 2022 at booth #1579 on March 14-18 in Orlando.

To learn more about the Apicare AuthAdivsor solution, visit www.apixio.com/apicare-authadvisor/.

About Apixio
Apixio is advancing healthcare with data-driven intelligence and analytics. Our Artificial Intelligence platform gives organizations across the healthcare spectrum the power to mine clinical information at scale, creating novel insights that will change the way healthcare is measured, care is delivered, and discoveries are made. Learn more at www.apixio.com.

#  #  #  #  #

MEDIA CONTACT:
Kerri Taranto
Next PR
267-589-9159
ktaranto@nextpr.com

AllStripes announces collaboration with Taysha Gene Therapies for SURF1-Associated Leigh syndrome program

SAN FRANCISCO (January 4, 2021) – AllStripes (formerly RDMD), a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced a multiyear collaboration with Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations.

The collaboration will focus on advancing the development of TSHA-104, an AAV9-based gene therapy in development for SURF1-associated Leigh syndrome, a deadly rare disease that primarily affects infants. AllStripes will use its platform, which gives patients control over their health histories, to unify otherwise scattered and fragmented SURF1-associated clinical data, allowing researchers to uncover new insights into the natural history and burden of disease and better inform the development of clinical studies.

“This collaboration will allow us to leverage the AllStripes technology platform to optimize our therapeutic strategy and to potentially accelerate the development of TSHA-104 in SURF1-associated Leigh syndrome,” said RA Session, II, president, founder and chief executive officer of Taysha. “We remain committed to developing a safe and effective gene therapy for patients suffering with this devastating disease, and data generated from this unique collaboration could bring us one step closer to our goal.”

Mutations in the SURF1 gene prevent mitochondria from producing enough energy for cells in the body to function normally, leading to Leigh syndrome, a severe and rare neurological disorder characterized by progressive loss of mental and movement abilities. SURF1-associated Leigh syndrome typically presents during infancy or early childhood, and often results in death within a few years. Approximately 10-15% of people with Leigh syndrome have a SURF1 mutation. There is currently no targeted treatment or cure for SURF1-associated Leigh syndrome.

“Taysha has brought together accomplished and knowledgeable gene therapy and CNS disease experts to develop potentially transformative therapies,” said Nancy Yu, co-founder and chief executive officer of AllStripes. “With no available treatment for SURF1-associated Leigh syndrome, we are very pleased to empower patients and their families with an avenue to participate in research that will support the development path of TSHA-104. We are hopeful that this novel gene therapy will bring meaningful benefit to children and their families, and give them more time together.”

TSHA-104 has been granted rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration (FDA) for the treatment of SURF1-associated Leigh syndrome. An Investigational New Drug (IND) application for TSHA-104 in SURF1-associated Leigh syndrome is expected to be submitted to the FDA in 2021.

About Taysha Gene Therapies

Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives. More information is available at www.tayshagtx.com.

About AllStripes

AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes has developed a technology platform that generates FDA-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, Spark Capital, Maveron Capital, Village Global, Garuda Ventures and a number of angel investors. For more information, visit www.allstripes.com.

War of Words Erupts Over Criticism of Medicare Advantage, APMs

Donald Berwick, M.D., and Richard Gilfillan, M.D., published an article in the Health Affairs Blog entitled “Medicare Advantage, Direct Contracting, And The Medicare ‘Money Machine,’ Part 2: Building on the ACO Model,” in which they criticized in the very strongest terms the new Direct Contracting program under Medicare, the ongoing evolution of the Medicare Advantage program, and some core aspects of the ways in which accountable care organizations (ACOs) are managed in the Medicare Shared Savings Program (MSSP). The Health Affairs blog by Drs. Berwick and Gilfillan was filled with intense criticism of Medicare Advantage of the way in which the MSSP is being run, and most of all, of the new Direct Contracting program. Among their core criticisms: the Medicare Advantage program is essentially providing private health insurance plans with a back door towards privatizing the Medicare program while not adding value, while the entire way in which risk is calculated both in MA and in the MSSP is riddled with errors and problems. The GEO Direct Contracting model was the most extreme, proposing to auto-assign every fee-for-service (FFS) beneficiary in a number of large geographic regions into a fully capitated MA-like “Geo DCE.” Beneficiaries were not given the right to opt out. This was, therefore, straightforward privatization of traditional Medicare, differing from MA only in that GEO Direct Contracting beneficiaries retained the right to see any Medicare provider under standard Medicare coverage.” Risk adjustment,” Crane emphasized, “was designed to estimate a beneficiary’s future health care costs and align compensation with acuity and severity of disease and the related costs of care as complex patients require the use of more resources. The adjusted compensation for high-risk patients provides physicians, healthcare organizations, and health plans resources to create additional programs and services to support and manage patients with important and impactful diseases and conditions

Google rolls out new search tools for health information on Medicare services, languages spoken by providers

Google is introducing new search features to make finding health information more accessible. The new search features build upon the tech behemoth’s efforts to offer “timely and authoritative” health information to empower people in their healthcare journeys, Budaraju wrote. The features augment other health-related consumer tools introduced by the company this year, including labeling COVID-19 vaccination sites on Google Maps and offering self-assessments for mental health conditions like anxiety and depression through Google Health. While the tech giant previously took a siloed approach to healthcare, the company has focused this year on weaving health efforts into its existing business lines. Despite two reorgs in the Google Health division this summer and loss of department chief David Feinberg, M.D., to Cerner, Chief Health Officer Karen DeSalvo, M.D., said at HLTH 2021 this October that the company isn’t scaling back its healthcare efforts, but is simply adopting a broader strategy. “I want people to understand—from the moment I walked in the door, my remit, my work, has been not only to think about how we’re going to help the healthcare sector but what are we going to do to see that there’s authoritative information on all of our platforms,” she said. “It’s quite frankly one of the things that’s been most exciting to me about the company because we know that we can reach literally billions of people and give them good information to help them make better choices about their health or to navigate their care journey.” For investors and entrepreneurs, the headlines signal choppy waters ahead—venture capital dollars are slowing, startups are raising less money this year as investors remain cautious, valuations are down and public companies have seen their shares drop by double-digits amid market volatility. “I think this is one of the best times to be starting a company and one of the best times to be building responsibly,” said Hemant Taneja, managing partner at digital health venture capital firm General Catalyst said Wednesday at Collision 2022, a tech conference taking place in Toronto this week. Digital health and health tech still have significant value going forward, analysts say. Investors point out that digital health companies have stronger fundamentals than companies in the dot-com bubble. Digital health had a breakout year in 2021, with startups raising an eye-popping $29.1 billion across 729 deals, according to Rock Health, a venture fund dedicated to digital health. Digital health startups banked $6 billion in the first quarter of 2022—an eye-popping number compared to just three years ago—but investment fell significantly behind the $7.3 billion raised in the fourth quarter of 2021 and the trailing twelve month quarterly average of $7.1 billion, according to Rock Health. ‘Are you fundamentally a business that is going to generate great economics and profit?’ That’s a cultural shift companies have to go through,” Taneja said. These industry transformations are where great companies are going to start with mission-driven founders in this era,” Taneja said. It’s going to be about companies that are lean, mean, focused, and doing fewer things better,” he said. Digital health startups banked record-breaking $29.1B last year. “We’re seeing a shift overall in the environment to making sure that the companies out there are providing discrete value to customers,” Sunny Kumar, M.D., a physician and partner at GSR Ventures, told Fierce Healthcare in an interview. GSR Venture invests in early-stage digital health companies. Healthcare is more resilient in a period of downturn, but the trends we’re seeing today, whether recession or inflation, is going to affect every single large enterprise, whether health systems, pharma and device companies. Jun 23, 2022 04:45pm Jun 23, 2022 04:00pm Jun 23, 2022 03:38pm Jun 23, 2022 03:25pm On Sunday, The Spokesman-Review reported that a draft Office of Inspector General report has flagged serious patient safety risks with the new EHR system. The Department of Veterans Affairs (VA) will push off deployment of a new electronic medical records system to additional medical facilities until 2023 to address outages that have plagued the software at current sites. The VA had planned to deploy the new health records software, which was developed by Cerner, now owned by Oracle, at the Puget Sound VA Health Care System, including American Lake and Seattle VA Medical Centers, this August, but will now push that project to March 2023 instead, a VA spokesperson confirmed. Plans to deploy the platform to the VA Portland Health Care System at the Portland and Portland-Vancouver VA Medical Centers has been delayed from this November to April 2023. "VA has consistently communicated that it will review each site’s readiness for deployment to ensure a successful and safe transition to the new EHR," the VA spokesperson said. On Sunday, The Spokesman-Review reported that a draft VA Office of Inspector General report has flagged serious patient safety risks with the new system. The date was changed to allow Oracle Cerner to put important system enhancements in place and make the necessary improvements to ensure system stability, securing the 99.9% uptime Service Level Agreement (SLA) currently contracted, as well as fix outstanding issues to address research workflow challenges," the VA spokesperson said. Deborah Hellinger, vice president of global corporate communications at Oracle, said in a statement that Oracle engineers have already been on the ground making technical and operational changes, "with an emphasis on patient safety, to ensure the system exceeds the expectations of providers, patients, and the VA." "We intend to bring substantially more resources to this program and deliver a modern, state-of-the-art electronic health system that will make the VA the industry standard. Under new legislation headed to President Joe Biden's desk, the VA will be required to submit regular reports to Congress about the performance of its new $16 billion medical records system, including incidents that risk patient safety. The new EHR system, developed by Cerner, now owned by Oracle, was first rolled out to Mann-Grandstaff VA Medical Center in Spokane, Washington, in November 2020, following two monthslong delays to address the department's information technology infrastructure and training and respond to the COVID-19 pandemic. In May, VA Secretary Denis McDonough told the House VA Committee that he's “very concerned about execution of the program to date,” but will press ahead with the EHR rollout, Federal News Network reported. McDonough said the new EHR from Cerner has experienced five shutdowns since March 3, the first of which was so “egregious” that the company’s CEO issued a signed apology, the media outlet reported. "VA is requesting that Oracle Cerner develop an execution plan to put this regular testing and confirmation of resiliency in place," officials said.

Sharing Genomic Data for Patient Care – Sync for Genes Phase 4 Wraps Up

Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a partnership with Epic, the industry leading healthcare software company, to integrate Myriad’s full line of genetic tests with Epic’s expansive network of 600,000 physicians and more than 250 million patients. The integration creates a seamless, end-to-end workflow solution for healthcare providers to order Myriad tests and review results directly within their everyday Epic platform without additional steps or manual ordering processes. With the ability to review pertinent health information, order tests, and receive results natively in Epic, providers will have the critical genetic insights and related information they need to drive better health outcomes and improve the patient experience. Increasing access to genetic insights and integrating our tests into Epic’s vast network of healthcare systems represents a significant step forward to better serve patients and healthcare providers.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the integration of the company’s genetic tests with Epic’s network of physicians and patients and the expected timing of the integration; the company’s growth plan to scale customer-centric, tech-enabled commercial capabilities with 600+ EHR integrations this year; the anticipated benefits of the integration, including that the integration will create an end-to-end workflow solution for healthcare providers to order Myriad tests and review results directly with their everyday Epic workflows, provide providers with critical genetic insights and related information they need to drive better health outcomes and improve the patient experience, and allow patients to easily access their Myriad test results directly from their EHR portal; and the company’s strategic imperatives under the caption. These “forward-looking statements” are management’s present expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those described in the forward-looking statements.

More Hospital Systems Embracing Anchor Role

Healthcare Anchor Network’s David Zuckerman and Atrium Health’s Kinneil Coltman describe ways health systems are advocating for changes in policy on housing, transportation and food insecurity. During a recent webinar, David Zuckerman, president and founder of the Healthcare Anchor Network (HAN), gave several examples of ways that health systems are using their roles as large employers to make community investments and partner with other community groups to advocate for changes in policy on housing, transportation and food insecurity. The health system members of HAN embrace their roles as catalysts for health, economic, and racial equity by leveraging their everyday operations, including hiring, purchasing, and investment for equitable, local economic impact and to build community wealth. “Our focus has been how to consistently change your institutional behaviors, but one of the things we learned early on was that there was also a need to help health systems be more effective advocates around a broader vision of health equity,” Zuckerman said.

Trinity Health worked in coalition with community partners to advocate for the Cares Act funds for rental and utility assistance in Idaho. “It's really important that they brought their voice to a broad coalition to help create the enactment of the Idaho Fair Warning Act, which gives tenants notice before eviction.” In the other example, UMass Memorial Health in Worcester was part of a coalition to help allocate ARPA funding for housing, including the first affordable housing trust fund in the city of Worcester, Massachusetts. “I think that this is a really important shift that we're seeing around these organizations being involved in other areas of social determinants of health policy that are so critical to helping us achieve health equity in this country,” he said. As the largest employer in North Carolina, Atrium Health is rethinking its social impact on the community. Atrium had been building a lot of infrastructure around health equity for a long time, Coltman said, “so when COVID started to roll into our communities, we had seen some of the headlines pouring in from other parts of the country about the profound and dramatic disparities along racial and socio-economic lines related to COVID, and we did not want to see that happen.”